Allergy-specific nanoparticles target immune cells, prevent anaphylaxis

Researchers have created a nanotherapy that selectively targets and shuts down the immune cells responsible for causing an allergic response in mice, preventing anaphylaxis. Able to be tailored to specific allergens, the novel nanomedicine could be the first to prevent allergic reactions.